Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGL PYGM	6.56e-05	3	94	2	GO:0008184
GeneOntologyMolecularFunction	histone modifying activity	SETMAR BRCA2 SETBP1 ASH1L KDM2B PRKDC SUZ12	1.05e-04	229	94	7	GO:0140993
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETMAR SETBP1 ASH1L	1.09e-04	20	94	3	GO:0042800
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DENND10 TIAM1 KALRN RALGPS1 RIN2 ARHGEF38 DENND4C	1.10e-04	231	94	7	GO:0005085
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGL PYGM	2.17e-04	5	94	2	GO:0004645
GeneOntologyMolecularFunction	histone methyltransferase activity	SETMAR SETBP1 ASH1L SUZ12	3.52e-04	71	94	4	GO:0042054
GeneOntologyBiologicalProcess	chromatin organization	TPR SETMAR GATAD2A ATRX BRCA2 SETBP1 ASH1L TOPBP1 KDM2B SMARCC2 ZNF518B PRKDC SUZ12 TEX15 IFI16	1.08e-05	896	93	15	GO:0006325
GeneOntologyBiologicalProcess	chromatin remodeling	TPR SETMAR GATAD2A ATRX BRCA2 SETBP1 ASH1L KDM2B SMARCC2 PRKDC SUZ12 TEX15 IFI16	2.75e-05	741	93	13	GO:0006338
GeneOntologyBiologicalProcess	protein-DNA complex organization	TPR SETMAR GATAD2A ATRX BRCA2 SETBP1 ASH1L TOPBP1 KDM2B SMARCC2 ZNF518B PRKDC SUZ12 TEX15 IFI16	3.85e-05	999	93	15	GO:0071824
GeneOntologyBiologicalProcess	ribosomal subunit export from nucleus	RAN ABCE1 NMD3	4.76e-05	16	93	3	GO:0000054
GeneOntologyBiologicalProcess	ribosome localization	RAN ABCE1 NMD3	4.76e-05	16	93	3	GO:0033750
GeneOntologyBiologicalProcess	nuclear DNA replication	ATRX BRCA2 ATAD5 CDC7	5.47e-05	46	93	4	GO:0033260
GeneOntologyBiologicalProcess	cell cycle DNA replication	ATRX BRCA2 ATAD5 CDC7	8.23e-05	51	93	4	GO:0044786
GeneOntologyBiologicalProcess	mitotic cell cycle process	CUL3 TPR RAN SETMAR ANK3 BRCA2 ATAD5 TOPBP1 SMARCC2 PRKDC ACVR1B USH1C CDC7	1.16e-04	854	93	13	GO:1903047
GeneOntologyBiologicalProcess	cell cycle phase transition	CUL3 TPR SETMAR BRCA2 ATAD5 TOPBP1 SMARCC2 PRKDC ACVR1B USH1C CDC7	1.19e-04	627	93	11	GO:0044770
GeneOntologyBiologicalProcess	RNA import into nucleus	TPR RAN	1.20e-04	4	93	2	GO:0006404
GeneOntologyBiologicalProcess	DNA-templated DNA replication	SETMAR ATRX BRCA2 ATAD5 TOPBP1 CDC7	1.55e-04	178	93	6	GO:0006261
GeneOntologyBiologicalProcess	mitotic cell cycle	CUL3 TPR RAN SETMAR AFAP1L2 ANK3 BRCA2 ATAD5 TOPBP1 SMARCC2 PRKDC ACVR1B USH1C CDC7	1.74e-04	1014	93	14	GO:0000278
GeneOntologyBiologicalProcess	chromosome organization	CUL3 TPR RAN SETMAR ATRX BRCA2 TOPBP1 SMARCC2 SGO2 PRKDC TEX15	2.61e-04	686	93	11	GO:0051276
GeneOntologyBiologicalProcess	NMDA selective glutamate receptor signaling pathway	TIAM1 KALRN	2.98e-04	6	93	2	GO:0098989
Domain	PHOSPHORYLASE	PYGL PYGM	7.02e-05	3	91	2	PS00102
Domain	Phosphorylase	PYGL PYGM	7.02e-05	3	91	2	PF00343
Domain	Glycg_phsphrylas	PYGL PYGM	7.02e-05	3	91	2	IPR011833
Domain	Glyco_trans_35	PYGL PYGM	7.02e-05	3	91	2	IPR000811
Domain	ZF_PHD_2	ATRX PHF3 ASXL3 ASH1L KDM2B	1.01e-04	95	91	5	PS50016
Domain	ZF_PHD_1	ATRX PHF3 ASXL3 ASH1L KDM2B	1.06e-04	96	91	5	PS01359
Domain	Znf_FYVE_PHD	ATRX SYTL5 PHF3 ASH1L KDM2B	7.62e-04	147	91	5	IPR011011
Domain	SAM	STIM2 DLC1 ANKS1B SAMD4A	9.00e-04	88	91	4	SM00454
Domain	ABC_transporter_CS	ABCE1 ABCC5 ABCC12	1.12e-03	42	91	3	IPR017871
Domain	SAM_DOMAIN	STIM2 DLC1 ANKS1B SAMD4A	1.20e-03	95	91	4	PS50105
Domain	SAM	STIM2 DLC1 ANKS1B SAMD4A	1.29e-03	97	91	4	IPR001660
Domain	ABC_tran	ABCE1 ABCC5 ABCC12	1.65e-03	48	91	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCE1 ABCC5 ABCC12	1.65e-03	48	91	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCE1 ABCC5 ABCC12	1.75e-03	49	91	3	PS00211
Domain	ABC_transporter-like	ABCE1 ABCC5 ABCC12	1.86e-03	50	91	3	IPR003439
Domain	SAM/pointed	STIM2 DLC1 ANKS1B SAMD4A	2.57e-03	117	91	4	IPR013761
Domain	Post-SET_dom	SETMAR ASH1L	2.70e-03	16	91	2	IPR003616
Domain	GATA_ZN_FINGER_1	GATAD2A ATRX	2.70e-03	16	91	2	PS00344
Domain	PostSET	SETMAR ASH1L	2.70e-03	16	91	2	SM00508
Domain	GATA_ZN_FINGER_2	GATAD2A ATRX	2.70e-03	16	91	2	PS50114
Domain	POST_SET	SETMAR ASH1L	2.70e-03	16	91	2	PS50868
Domain	DH_1	TIAM1 KALRN ARHGEF38	3.60e-03	63	91	3	PS00741
Domain	RhoGEF	TIAM1 KALRN ARHGEF38	4.46e-03	68	91	3	SM00325
Domain	RhoGEF	TIAM1 KALRN ARHGEF38	4.84e-03	70	91	3	PF00621
Domain	DH_2	TIAM1 KALRN ARHGEF38	4.84e-03	70	91	3	PS50010
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	RPL21 TPR RAN RPL32 ATRX BRCA2 ATAD5 UTP14A TOPBP1 SMARCC2 SGO2 PYGM PRKDC	2.68e-08	652	95	13	31180492
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RPL21 CUL3 RPL32 GATAD2A ATAD5 PHF3 STRBP UTP14A TOPBP1 SGO2 PRKDC SUZ12 SRBD1	1.55e-07	759	95	13	35915203
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	CUL3 GATAD2A ATAD5 PHF3 STRBP UTP14A TOPBP1 SMARCC2 SUZ12	8.32e-07	370	95	9	22922362
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF567 GATAD2A ATRX ATAD5 PHF3 TOPBP1 KDM2B SMARCC2 SGO2 SUZ12 SRBD1	8.82e-07	608	95	11	36089195
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR GATAD2A ATRX PHF3 STRBP UTP14A PRKDC IFI16	1.15e-06	283	95	8	30585729
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR RAN GATAD2A ATRX BRCA2 ATAD5 PHF3 STRBP UTP14A TOPBP1 SMARCC2 SGO2 PRKDC	2.01e-06	954	95	13	36373674
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZNF7 TARS3 SETMAR GTF3A ANK3 TIAM1 ATRX KALRN KCNJ6 ASH1L ANKS1B CCDC15 ABCC5 SYT4 PRKDC	2.08e-06	1285	95	15	35914814
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL21 RAN RPL32 GATAD2A ATRX ATAD5 PHF3 TOPBP1 KDM2B PRKDC SUZ12 SRBD1 IFI16 MXD4 SAMD4A	2.26e-06	1294	95	15	30804502
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL3 TPR RAN GATAD2A ATRX ATAD5 ABCE1 PHF3 SMARCC2 PYGL PRKDC SUZ12 IFI16	3.90e-06	1014	95	13	32416067
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	TPR ATRX PHF3 UTP14A SGO2	4.00e-06	86	95	5	37253089
Pubmed	MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function.	ABCC5 ABCC12	7.38e-06	2	95	2	35121660
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL21 RAN STIM2 ATRX PYROXD1 STRBP FAM186A TRO UTP14A ASH1L ANKS1B ABCC5 SMARCC2 PRKDC SRBD1	8.36e-06	1442	95	15	35575683
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	ATRX ATAD5 PHF3 UTP14A SMARCC2 SRBD1	9.53e-06	177	95	6	26206133
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	CUL3 ANK3 KALRN PHF3 ANKS1B AKAP11 SIK3	1.26e-05	281	95	7	28706196
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	RPL21 GATAD2A DSC2 ATRX ATAD5 UTP14A ASH1L SMARCC2 SUZ12	1.59e-05	533	95	9	30554943
Pubmed	Nucleolar proteome dynamics.	RPL21 TPR RAN POP4 ATRX TOPBP1 PRKDC NMD3	2.02e-05	419	95	8	15635413
Pubmed	Coordinated nuclear export of 60S ribosomal subunits and NMD3 in vertebrates.	RAN NMD3	2.21e-05	3	95	2	12773398
Pubmed	Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway.	RAN NMD3	2.21e-05	3	95	2	12724356
Pubmed	Mutation and expression alterations of histone methylation-related NSD2, KDM2B and SETMAR genes in colon cancers.	SETMAR KDM2B	2.21e-05	3	95	2	33621919
Pubmed	Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.	KDM2B SUZ12	2.21e-05	3	95	2	28124441
Pubmed	The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.	IGFBP3 PRKDC	2.21e-05	3	95	2	23178489
Pubmed	Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.	ANK3 TIAM1	2.21e-05	3	95	2	10893266
Pubmed	Expression of Tiam-1 in the developing brain suggests a role for the Tiam-1-Rac signaling pathway in cell migration and neurite outgrowth.	TIAM1 KCNJ6	2.21e-05	3	95	2	9204476
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RPL21 TPR RAN STIM2 ANK3 DSC2 ABCE1 ABCC5 PRKDC DENND4C	2.45e-05	708	95	10	39231216
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	RPL21 RAN STRBP UTP14A TOPBP1 SMARCC2 SGO2 SYT4 SRBD1 NMD3	2.92e-05	723	95	10	34133714
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	AP4E1 SETMAR POP4 GSDME DSC2 DACT3 ARHGEF38 ANKS1B SGO2 SIK3 USH1C C3orf20 DENND4C	3.33e-05	1242	95	13	30973865
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	FAM32A ATRX BRCA2 TOPBP1 ZNF518B CDC7	3.42e-05	222	95	6	37071664
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	STIM2 GATAD2A ATRX ABCE1 RIN2 MRPL30 AKAP11 ACVR1B SIK3 SLC4A4 CDC7	3.91e-05	910	95	11	36736316
Pubmed	OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling.	OXTR PRKDC	4.41e-05	4	95	2	36045118
Pubmed	Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.	RHOQ RAN	4.41e-05	4	95	2	2108320
Pubmed	Elevated HMGN4 expression potentiates thyroid tumorigenesis.	ATRX BRCA2	4.41e-05	4	95	2	28186538
Pubmed	The mouse interferon-inducible gene Ifi204 product interacts with the Tpr protein, a component of the nuclear pore complex.	TPR IFI16	4.41e-05	4	95	2	12513910
Pubmed	Characteristics of DNA-binding proteins determine the biological sensitivity to high-linear energy transfer radiation.	ATRX PRKDC	4.41e-05	4	95	2	20150414
Pubmed	Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.	TPR RAN ABCE1 PTDSS1 PYGL PRKDC	5.40e-05	241	95	6	23125841
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	RPL21 AP4E1 RAN STIM2 DSC2 ABCE1 PTDSS1 ABCC5 PYGL AKAP11 SLC4A4	5.87e-05	952	95	11	38569033
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CUL3 ANK3 MYOM1 DSC2 PHF3 ASXL3 PRKDC	6.19e-05	361	95	7	26167880
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	GATAD2A ATRX ASH1L KDM2B SMARCC2	7.34e-05	157	95	5	30186101
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RPL21 TPR ABCE1 PHF3 STRBP UTP14A SMARCC2 PYGL PRKDC	7.68e-05	653	95	9	22586326
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RPL21 RAN RPL32 POP4 PHF3 STRBP UTP14A SMARCC2 PRKDC SRBD1 NMD3	8.24e-05	989	95	11	36424410
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	RPL21 RPL32 SETMAR ASXL3 SETBP1 KDM2B PRKDC CSMD3	8.39e-05	513	95	8	25798074
Pubmed	BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.	ATRX BRCA2	1.10e-04	6	95	2	28976962
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	GATAD2A KDM2B SMARCC2 PYGL ZNF518B PRKDC SUZ12	1.13e-04	398	95	7	35016035
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	RPL32 AFAP1L2 DSC2 ATRX KALRN ASXL3 ABCC5 AKAP11	1.39e-04	552	95	8	10737800
Pubmed	Ion channel expression in the developing enteric nervous system.	ANK3 KCNJ6 KCNN2	1.43e-04	37	95	3	25798587
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	RAN RPL32 GATAD2A SMARCC2 PRKDC	1.47e-04	182	95	5	26527279
Pubmed	ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.	ATRX SUZ12	1.54e-04	7	95	2	31631027
Pubmed	CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.	CUL3 DLC1	1.54e-04	7	95	2	24082123
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	DLC1 TIAM1 ARHGEF38	1.55e-04	38	95	3	19911011
Pubmed	Quantitative nanoproteomics for protein complexes (QNanoPX) related to estrogen transcriptional action.	CUL3 RAN PRKDC	1.95e-04	41	95	3	19805454
Pubmed	Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice.	ABCC5 ABCC12	2.05e-04	8	95	2	15802388
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	RAN RPL32 DSC2 ATRX ABCE1 PYGL PRKDC	2.13e-04	441	95	7	31239290
Pubmed	The polyproline-motif of S6K2: eIF5A translational dependence and importance for protein-protein interactions.	RPL21 RPL32 ZNF90	2.41e-04	44	95	3	30320934
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	BRCA2 ATAD5 PHF3 TOPBP1 SMARCC2 SGO2 IFI16	2.50e-04	453	95	7	29656893
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RPL21 TPR GATAD2A ATAD5 STRBP UTP14A SMARCC2 PRKDC	2.58e-04	605	95	8	28977666
Pubmed	A mechanism for the suppression of homologous recombination in G1 cells.	CUL3 BRCA2	2.62e-04	9	95	2	26649820
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CUL3 TPR ATRX PHF3 KDM2B SMARCC2 PRKDC SUZ12 IFI16	2.73e-04	774	95	9	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	AP4E1 RAN STIM2 ANK3 DSC2 UTP14A ABCC5 PRKDC ACVR1B	2.81e-04	777	95	9	35844135
Pubmed	Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.	RPL21 TPR PTDSS1 SMARCC2 PRKDC SRBD1	3.13e-04	333	95	6	36779763
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL21 TPR RAN GATAD2A ABCE1 UTP14A SMARCC2 PYGL PRKDC SRBD1 IFI16 NMD3	3.18e-04	1353	95	12	29467282
Pubmed	Polycomb repressive complexes 1 and 2 are each essential for maintenance of X inactivation in extra-embryonic lineages.	ATRX SUZ12	3.28e-04	10	95	2	36635505
Pubmed	Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group.	ZNF7 DLC1	3.28e-04	10	95	2	19795399
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	GATAD2A ATAD5 ABCE1 STRBP ASXL3 KDM2B SMARCC2 SIK3	3.68e-04	638	95	8	31182584
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	STIM2 DLC1 RIN2 PTDSS1 ANKS1B KCNN2 IFI16 C19orf18 SAMD4A	3.94e-04	814	95	9	23251661
Pubmed	Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.	BRCA2 TOPBP1	4.00e-04	11	95	2	19584272
Pubmed	FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16.	BRCA2 PRKDC	4.00e-04	11	95	2	18406329
Pubmed	CUL3-KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling.	CUL3 TIAM1	4.00e-04	11	95	2	25684205
Pubmed	Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation.	KDM2B PRKDC	4.00e-04	11	95	2	26237645
Pubmed	Neural progenitor genes. Germinal zone expression and analysis of genetic overlap in stem cell populations.	RHOQ RAN IGFBP3	4.19e-04	53	95	3	14651920
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	TPR RAN SMARCC2 PRKDC	4.30e-04	128	95	4	23858473
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR GATAD2A KALRN PHF3 TOPBP1 IFI16 DENND4C	4.69e-04	503	95	7	16964243
Pubmed	Intrinsically Disordered Protein TEX264 Mediates ER-phagy.	GATAD2A ABCE1 SMARCC2 AKAP11	4.69e-04	131	95	4	31006538
Pubmed	Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth.	ATAD5 SUZ12	4.79e-04	12	95	2	17632510
Pubmed	Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.	BRCA2 TOPBP1	4.79e-04	12	95	2	16391231
Pubmed	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	TIAM1 KALRN ASXL3 CCDC15	5.11e-04	134	95	4	24324551
Pubmed	BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.	BRCA2 PYGM DCST2	5.19e-04	57	95	3	27433848
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL21 TPR RPL32 GATAD2A PHF3 PTDSS1 SMARCC2 PRKDC IFI16	5.25e-04	847	95	9	35850772
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	RPL21 TPR RAN GATAD2A TRO MRPL30 TOPBP1 SMARCC2 PRKDC	5.25e-04	847	95	9	35235311
Pubmed	Identification and sequencing the juvenile spermatogonial depletion critical interval on mouse chromosome 1 reveals the presence of eight candidate genes.	CUL3 UTP14A	5.65e-04	13	95	2	11700028
Pubmed	IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.	IGFBP3 PRKDC	5.65e-04	13	95	2	30725116
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	RPL21 CUL3 RAN RPL32 PRKDC	5.66e-04	244	95	5	30349055
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RPL21 TPR GATAD2A STRBP TRO UTP14A CCDC15 SMARCC2 MXD4	5.70e-04	857	95	9	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STIM2 DLC1 DSC2 TIAM1 PHF3 AKAP11 SIK3 DENND4C SAMD4A	5.90e-04	861	95	9	36931259
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RPL21 TPR RHOQ RAN RPL32 ABCE1 PHF3 UTP14A KDM2B SMARCC2 PRKDC	5.99e-04	1247	95	11	27684187
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	CUL3 AFAP1L2 GTF3A PHF3 ASH1L PYGL SIK3 SAMD4A	6.10e-04	689	95	8	36543142
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CUL3 RALGPS1 SETBP1 TOPBP1 KDM2B AKAP11 SIK3	6.32e-04	529	95	7	14621295
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL21 CUL3 TPR RAN RPL32 GATAD2A PHF3 UTP14A PRKDC SRBD1 IFI16	6.40e-04	1257	95	11	36526897
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	CUL3 ATRX PHF3 STRBP UTP14A	6.43e-04	251	95	5	28077445
Pubmed	Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.	IGFBP3 BRCA2	6.58e-04	14	95	2	17018785
Pubmed	Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.	PHF3 ASH1L	6.58e-04	14	95	2	28263302
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RPL21 RPL32 STIM2 ANK3 DSC2 TIAM1 ATRX ATAD5 UTP14A PTDSS1 AKAP11 SIK3	7.35e-04	1487	95	12	33957083
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	GATAD2A ATRX ATAD5 SMARCC2 PRKDC SUZ12	7.57e-04	394	95	6	27248496
Pubmed	Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.	PYGL PYGM	7.57e-04	15	95	2	2575583
Pubmed	Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage.	RPL21 RPL32 BRCA2 TOPBP1	7.61e-04	149	95	4	25184681
Pubmed	A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.	BRCA2 ATAD5 CDC7	7.63e-04	65	95	3	27453043
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	RPL21 CUL3 TPR PYGM PRKDC	8.48e-04	267	95	5	33417871
Pubmed	Characterization of human colon cancer antigens recognized by autologous antibodies.	UTP14A USH1C	8.64e-04	16	95	2	9610721
Pubmed	Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications.	BRCA2 TOPBP1	8.64e-04	16	95	2	27760317
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	RPL21 TPR RAN STRBP SMARCC2	9.06e-04	271	95	5	32433965
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CUL3 RPL32 ANK3 TIAM1 ATRX PTDSS1 DACT3 PYGL USH1C DENND4C CDC7	9.60e-04	1321	95	11	27173435
Pubmed	MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair.	TPR PRKDC	9.78e-04	17	95	2	20479123
Interaction	H2BC8 interactions	CUL3 GATAD2A ATRX ATAD5 PHF3 UTP14A TOPBP1 KDM2B SMARCC2 SGO2 AKAP11 SUZ12 SRBD1	3.03e-06	576	95	13	int:H2BC8
Interaction	UHRF2 interactions	CUL3 TPR ATRX PHF3 UTP14A SGO2 PRKDC SUZ12	4.75e-06	200	95	8	int:UHRF2
Interaction	CBX3 interactions	CUL3 ZNF567 RAN ATRX ATAD5 ABCE1 PHF3 UTP14A TOPBP1 KDM2B ZNF518B SUZ12 IFI16	1.04e-05	646	95	13	int:CBX3
Interaction	H3-3A interactions	CUL3 ZNF567 GATAD2A TIAM1 ATRX ATAD5 PHF3 ASH1L TOPBP1 KDM2B SMARCC2 PRKDC SUZ12 SRBD1	1.07e-05	749	95	14	int:H3-3A
Interaction	H1-2 interactions	CUL3 RAN RHBDL2 ATRX ABCE1 PHF3 STRBP ASXL3 TOPBP1 AKAP11 PRKDC SUZ12 IFI16	1.44e-05	666	95	13	int:H1-2
Interaction	RAD9A interactions	SETMAR ATRX BRCA2 ATAD5 TOPBP1	1.49e-05	66	95	5	int:RAD9A
Interaction	POLR1G interactions	POP4 GATAD2A FAM32A ATAD5 PHF3 STRBP UTP14A TOPBP1 KDM2B SMARCC2 SGO2	1.91e-05	489	95	11	int:POLR1G
Interaction	H2BC21 interactions	CUL3 GATAD2A ATRX ATAD5 PHF3 SMARCC2 SGO2 AKAP11 ZNF518B PRKDC SUZ12 SRBD1 IFI16	2.29e-05	696	95	13	int:H2BC21
Interaction	CSNK2A1 interactions	RPL21 CUL3 IGFBP3 GATAD2A ATRX ATAD5 ABCE1 ASXL3 UTP14A KDM2B SMARCC2 PRKDC SRBD1 IFI16 NMD3	3.91e-05	956	95	15	int:CSNK2A1
Interaction	H2BC9 interactions	RPL21 RAN ATRX TRO SETBP1 ASH1L SMARCC2 AKAP11 TEX15 USH1C	4.81e-05	446	95	10	int:H2BC9
Interaction	ZNF330 interactions	CUL3 GATAD2A ATAD5 PHF3 UTP14A TOPBP1 KDM2B SMARCC2 SUZ12 SRBD1	4.81e-05	446	95	10	int:ZNF330
Interaction	DCST2 interactions	BRCA2 DCST2	6.58e-05	3	95	2	int:DCST2
Interaction	H3C1 interactions	TPR RAN RPL32 GATAD2A ANK3 ATRX ATAD5 PHF3 ASH1L KDM2B SMARCC2 PRKDC SUZ12 SRBD1	8.08e-05	901	95	14	int:H3C1
Interaction	NUP107 interactions	CUL3 TPR RAN SIGLECL1 PRKDC SUZ12 IFI16	8.46e-05	221	95	7	int:NUP107
Interaction	H3C3 interactions	GATAD2A ATRX ATAD5 PHF3 TOPBP1 KDM2B SMARCC2 SGO2 SUZ12 SRBD1	1.14e-04	495	95	10	int:H3C3
Cytoband	Ensembl 112 genes in cytogenetic band chr18q12	DSC2 ASXL3 SETBP1 SYT4	6.75e-05	104	95	4	chr18q12
Cytoband	1q22	ASH1L DCST2 IFI16	2.32e-04	57	95	3	1q22
Cytoband	Xq26.1	DENND10P1 UTP14A	4.99e-04	16	95	2	Xq26.1
GeneFamily	Glycogen phosphorylases	PYGL PYGM	3.81e-05	3	65	2	437
GeneFamily	ATP binding cassette subfamily C	ABCC5 ABCC12	9.68e-04	13	65	2	807
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TIAM1 KALRN ARHGEF38	1.73e-03	66	65	3	722
GeneFamily	Sterile alpha motif domain containing	STIM2 ANKS1B SAMD4A	3.91e-03	88	65	3	760
GeneFamily	PHD finger proteins	PHF3 ASH1L KDM2B	4.17e-03	90	65	3	88
Coexpression	CHICAS_RB1_TARGETS_GROWING	TPR OXTR IGFBP3 ATRX KCNN2 SGO2 PYGL IFI16 CDC7	2.48e-07	242	95	9	M2128
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	STIM2 ANK3 ATRX ASXL3 RALGPS1 DACT3 ANKS1B KDM2B ABCC5 SMARCC2 OPN5 SYT4 ACVR1B SIK3 CSMD3	1.02e-05	1106	95	15	M39071
Coexpression	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	RPL21 SETMAR ANK3 PYROXD1 UTP14A IFI16	1.50e-05	145	95	6	M2137
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	GSDME ANK3 KALRN ASXL3 RALGPS1 KCNJ6 OPN5 SYT4 SLC4A4 CSMD3	5.16e-05	584	95	10	M39068
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	ANK3 TIGIT BRCA2 ATAD5 SGO2 IFI16	5.54e-05	183	95	6	M2993
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DLC1 TIAM1 ATRX BRCA2 ABCE1 PHF3 RIN2 TOPBP1 AKAP11 SUZ12 SIK3 SAMD4A	6.20e-05	856	95	12	M4500
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	TPR GSDME ATRX PYROXD1 ABCE1 ABCC5 AKAP11 PRKDC CDC7	6.37e-05	481	95	9	M3898
Coexpression	PUJANA_BRCA_CENTERED_NETWORK	BRCA2 TOPBP1 PRKDC SUZ12 CDC7	7.12e-05	118	95	5	M15305
Coexpression	GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP	RAN GTF3A UTP14A SGO2 TSSK3 SRBD1	9.05e-05	200	95	6	M6555
Coexpression	GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN	ZNF7 IGFBP3 TIAM1 CCR9 MXD4 CDC7	9.05e-05	200	95	6	M7231
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	ZNF7 CUL3 TPR POP4 GSDME ANK3 TIGIT ATRX BRCA2 ATAD5 STRBP ASXL3 SGO2 CPA2 ZNF518B SUZ12 SLC4A4 NMD3 CDC7	1.75e-06	1241	94	19	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	ZNF7 CUL3 TPR POP4 GSDME GTF3A BRCA2 ASXL3 SGO2 CPA2 SUZ12	1.13e-05	492	94	11	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	ZNF7 CUL3 TPR GSDME BRCA2 SGO2 SUZ12	1.90e-05	186	94	7	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	ZNF7 CUL3 TPR POP4 GSDME ANK3 TIGIT ATRX BRCA2 ATAD5 STRBP ASXL3 SGO2 CPA2 ZNF518B SUZ12 SLC4A4 NMD3 CDC7	1.96e-05	1468	94	19	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	ZNF7 CUL3 POP4 BRCA2 ATAD5 PHF3 UTP14A SGO2 ZNF518B PRKDC SUZ12	2.33e-05	532	94	11	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ZNF7 CUL3 TPR POP4 DENND10 TIGIT ATRX BRCA2 PYROXD1 ATAD5 PHF3 STRBP SETBP1 SGO2 ZNF518B SUZ12 NMD3	3.32e-05	1257	94	17	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	ZNF7 CUL3 TPR POP4 DENND10 TIGIT ATRX BRCA2 PYROXD1 ATAD5 PHF3 STRBP SETBP1 ANKS1B SGO2 ZNF518B SUZ12 NMD3	6.29e-05	1459	94	18	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	ZNF7 TPR POP4 GSDME GTF3A BRCA2 ASXL3 SGO2	1.11e-04	331	94	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATRX BRCA2 ATAD5 STRBP UTP14A PRKDC	2.13e-04	192	94	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR DLC1 ANK3 ATRX PHF3 SERAC1 ZNF518B SLC4A4	2.34e-04	369	94	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR DSC2 ATRX PHF3 STRBP ASH1L AKAP11 SLC4A4	7.42e-09	191	94	8	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR DSC2 ATRX PHF3 STRBP ASH1L AKAP11 SLC4A4	7.42e-09	191	94	8	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR DSC2 ATRX PHF3 STRBP ASH1L AKAP11 SLC4A4	7.42e-09	191	94	8	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLC1 MYOM1 DACT3 PYGM CSMD3 SAMD4A	2.95e-06	188	94	6	d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BRCA2 ATAD5 TOPBP1 CCDC15 PRKDC CDC7	3.75e-06	196	94	6	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	MS-IIF-Lymphocyte-T/NK-Treg\|IIF / Disease, condition lineage and cell class	RPL21 TPR RPL32 TIGIT KALRN ZNF90	3.97e-06	198	94	6	7bbf8403ecf9f8e403b04f18d265ece977cc49e7
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK3 KALRN STRBP SETBP1 ANKS1B CSMD3	3.97e-06	198	94	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	ANK3 KALRN STRBP SETBP1 ANKS1B CSMD3	4.21e-06	200	94	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	BRCA2 ATAD5 TOPBP1 SGO2 PRKDC CDC7	4.21e-06	200	94	6	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	BRCA2 ATAD5 TOPBP1 SGO2 PRKDC CDC7	4.21e-06	200	94	6	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 RPL32 ASXL3 PYGL CPA2	1.15e-05	139	94	5	c300f953ff9c5e820ff16bcd9942d279b37b79db
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 RPL32 ASXL3 PYGL CPA2	1.15e-05	139	94	5	95b19d7459d9b54162cf01d278462245d34802d5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AP4E1 POP4 TIAM1 TSSK3 CSMD3	1.61e-05	149	94	5	61d84838a841ed2d6b8c5f86d423a4e6b3dcc9cb
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OXTR TIAM1 PYGM CSMD3 GRPR	1.95e-05	155	94	5	99e749f7075e2c64e9a0bf91009f95b6969197c8
ToppCell	facs-Spleen-nan-24m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSDME RIN2 PYGL TEX15 USH1C	2.01e-05	156	94	5	034d4359359a44c205c6931f38a375271ac2752b
ToppCell	facs-Spleen-nan-24m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSDME RIN2 PYGL TEX15 USH1C	2.01e-05	156	94	5	2a4dac4100c0339aad4905b8eaca6e8fe806718b
ToppCell	facs-Spleen-nan-24m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSDME RIN2 PYGL TEX15 USH1C	2.01e-05	156	94	5	21267718d3a3dc19988663b6846aed8bb3eae836
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TIAM1 SYTL5 KCNN2 CSMD3 GRPR	2.34e-05	161	94	5	3b5d7a3dab479c6959a428f3954dedd989900276
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OXTR SYTL5 PYGM CSMD3 GRPR	2.63e-05	165	94	5	c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCell	Control\|World / group, cell type (main and fine annotations)	NTN4 DLC1 ANK3 ANKS1B SLC4A4	2.87e-05	168	94	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	IIF-Lymphocyte-T_NK-Treg\|IIF / Disease, Lineage and Cell Type	RPL21 TPR RPL32 TIGIT KALRN	2.95e-05	169	94	5	aac6ff89e0b3bc1f644e6cc6a696360659b254b5
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANK3 ATAD5 ASXL3 ARHGEF38 TEX15	3.04e-05	170	94	5	4ce81608111b9ee7cb974dad2c182f38db3dcd79
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OXTR ATRX SYTL5 ANKS1B ABCC12	3.68e-05	177	94	5	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GRID2IP BRCA2 ATAD5 SGO2 ITGAD	3.78e-05	178	94	5	dbde3305e0c6a81593fe614e3f2e746b32cc16a7
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	3.99e-05	180	94	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	4.32e-05	183	94	5	6847c1252d6bb105524f812658112517fd351eab
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFAP1L2 ANK3 ANKS1B SYT4 CSMD3	4.54e-05	185	94	5	3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b
ToppCell	droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFAP1L2 ANK3 ANKS1B SYT4 CSMD3	4.54e-05	185	94	5	995a8ddc3fd8e6879d8b5de8cbdefe232d34833b
ToppCell	droplet-Spleen-nan-3m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 TPR RPL32 ATRX CCR9	4.66e-05	186	94	5	26f1e9930adf2fe4af0819e56f69915bd8330e4a
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	4.91e-05	188	94	5	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.03e-05	189	94	5	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	COVID-19-Heart-CM_4\|Heart / Disease (COVID-19 only), tissue and cell type	RHBDL2 ANK3 PTDSS1 ABCC5 SLC4A4	5.16e-05	190	94	5	3729648a17093b438398b82e32bbccc3af7b8c5d
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	ATRX BRCA2 ATAD5 CCDC15 SGO2	5.29e-05	191	94	5	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.29e-05	191	94	5	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MYOM1 DSC2 KCNN2 PYGM	5.29e-05	191	94	5	c172c9e17b893b290e4aa8af5e5e4cd3e4818372
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MYOM1 DSC2 KCNN2 PYGM	5.29e-05	191	94	5	715f5b449b8e075959c05a5b38389df319663164
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.42e-05	192	94	5	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.42e-05	192	94	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 SETBP1 ASH1L SIK3 SLC4A4	5.42e-05	192	94	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.56e-05	193	94	5	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_TFH-like\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RPL21 RPL32 TIGIT TIAM1 IFI16	5.56e-05	193	94	5	88cc740dd216ea80605b857c27914a8bc6ba6771
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.56e-05	193	94	5	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.56e-05	193	94	5	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.69e-05	194	94	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	5.69e-05	194	94	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRCA2 ATAD5 CCDC15 PRKDC CDC7	5.83e-05	195	94	5	cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Tfh\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL21 RPL32 TIGIT TIAM1 ANKS1B	5.83e-05	195	94	5	b2ecab35db438c82872cd16a6e9f013475e559ef
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KALRN STRBP SETBP1 ANKS1B CSMD3	5.98e-05	196	94	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAN STIM2 TIGIT SETBP1 MXD4	5.98e-05	196	94	5	c9fb81a0578db6d278b8582d7b3add6c407e6dcf
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPL21 RPL32 TARS3 ANK3 TIAM1	5.98e-05	196	94	5	b10810c6a2ad3d3b968bfef46a68a38e0ce31331
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 ANK3 STRBP RALGPS1 ARHGEF38	5.98e-05	196	94	5	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RPL21 NTN4 RPL32 IGFBP3 ANK3	5.98e-05	196	94	5	6eabbac1625f715531bae562a28da27664572600
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPL21 RPL32 TARS3 CCR9 SIK3	5.98e-05	196	94	5	c647ce58de4c5bb4ceb1123690e637eae4ae1b82
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL21 RPL32 TIGIT TIAM1 CCR9	6.12e-05	197	94	5	a6eba89bb3e24ae973068f85a8bcc3094e985cb9
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	TPR ATRX KALRN PHF3 SMARCC2	6.12e-05	197	94	5	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Tfh\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPL21 RPL32 TIGIT TIAM1 ANKS1B	6.12e-05	197	94	5	144ca23372b3265007a1e508e48d320581cf5695
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_3\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	RPL21 NTN4 RPL32 ANKS1B CSMD3	6.12e-05	197	94	5	62c0682eb32a41c58d31ae33b23e7d61ce5a6abb
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TPR ATRX PHF3 ASH1L IFI16	6.27e-05	198	94	5	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KALRN STRBP SETBP1 ANKS1B CSMD3	6.27e-05	198	94	5	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ASXL3 KCNJ6 SYT4 TEX15 USH1C	6.27e-05	198	94	5	8f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KALRN STRBP SETBP1 ANKS1B CSMD3	6.27e-05	198	94	5	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KALRN STRBP SETBP1 ANKS1B CSMD3	6.27e-05	198	94	5	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	356C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RPL21 RAN RPL32 ANK3 ZNF90	6.27e-05	198	94	5	0f25a3bf2af543267b43e56064ad06dfc18c7bd7
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ASXL3 KCNJ6 SYT4 TEX15 USH1C	6.27e-05	198	94	5	e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NTN4 DLC1 ANK3 ARHGEF38 SLC4A4	6.42e-05	199	94	5	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Caecum-T_cell-Activated_CD4_T\|T_cell / Region, Cell class and subclass	RPL21 RPL32 ANK3 TIAM1 ASH1L	6.42e-05	199	94	5	13173cc4dcc8e856680372b0a4ad4f36afa892c1
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	RHOQ ATRX PHF3 ACVR1B IFI16	6.42e-05	199	94	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	VE-CD4-naive_CD4\|VE / Condition, Cell_class and T cell subcluster	RPL21 RPL32 ANK3 TIGIT TIAM1	6.42e-05	199	94	5	702e72fa93f18024b02fe3aad92cc1c3b2f6eb68
ToppCell	Neuron\|World / Primary Cells by Cluster	RPL32 ANK3 ATRX ASXL3 SYT4	6.42e-05	199	94	5	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	RPL32 ANK3 ATRX ASXL3 SYT4	6.42e-05	199	94	5	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	(1)_T_cell-(16)_Tfh\|(1)_T_cell / shred on Cell_type and subtype	RPL21 RPL32 DENND10 TIAM1 IFI16	6.58e-05	200	94	5	3b28137e8e69b98fde9f6ab8320cb4d1c3543ef9
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLC1 ATRX ASH1L ZNF518B IFI16	6.58e-05	200	94	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR ATRX PHF3 ASH1L IFI16	6.58e-05	200	94	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-dn_T\|ICU-SEP / Disease, condition lineage and cell class	TARS3 TIGIT KALRN DACT3 CCDC15	6.58e-05	200	94	5	9ee3e18dc429b9c472e3e366d9bfdbb150daa369
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IGFBP3 DSC2 SYTL5 OPN5	1.26e-04	121	94	4	2ae870f822488799cd0ad85e7f72af64e33a867f
ToppCell	control-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RPL21 RPL32 RHBDL2 ZNF90	1.56e-04	128	94	4	24abab941b4a2f89e13089d208d40ec02f0cad10
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA2 ATAD5 SGO2 TEX15	1.86e-04	134	94	4	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TIGIT TIAM1 SYTL5 GRPR	2.03e-04	137	94	4	d346086f42d8f04d3fa67fe696834284acdc7080
ToppCell	Control-B_naive-11\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RPL21 RPL32 TRO SIGLECL1	2.14e-04	139	94	4	2af7ad44b707d139c6f055e63d68c09b5c1bb1be
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TARS3 PYROXD1 SGO2 PRKDC	2.39e-04	143	94	4	b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TIAM1 SYTL5 CSMD3 GRPR	2.45e-04	144	94	4	7de962346ba9653d90dd13bb7d977fe44d200bba
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OXTR TIAM1 SYTL5 PYGM	2.59e-04	146	94	4	47368f981180ca6a8c81a50f7f9430f12456f609
ToppCell	Bac-SEP-Lymphocyte-T_NK-CD8_TCM\|Bac-SEP / Disease, Lineage and Cell Type	RPL21 RPL32 RHBDL2 ITGAD	2.72e-04	148	94	4	5814bfb5060bac455334eb50d2a7b1f01c0b6831
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	OXTR TIAM1 PYGM GRPR	2.80e-04	149	94	4	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARHGEF38 OPN5 ABCC12	3.05e-04	62	94	3	a20620a8869721ea62984c2022ee1b484b455824
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ARHGEF38 OPN5 ABCC12	3.05e-04	62	94	3	ee694c06bcd924b4ddf744178ba3a99e04eed51b
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TIAM1 SYTL5 CSMD3 GRPR	3.09e-04	153	94	4	9c6fce56300ba5053efda59a438d63a808c497c0
ToppCell	Severe-B_naive-5\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYOM1 DACT3 PYGL ACVR1B	3.09e-04	153	94	4	44572f87d403e314050ab935d2cd676c33d9c287
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-Tfh\|blood / Manually curated celltypes from each tissue	RPL21 TARS3 ANK3 CSMD3	3.17e-04	154	94	4	5ff380205fa7ab97ba21f6512bc9e14c0fb320b6
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM186A TEX15 ITGAD	3.20e-04	63	94	3	83e1c91f830aadaf13e13254ce30189fd434bcc9
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM186A TEX15 ITGAD	3.20e-04	63	94	3	f2532b1aa117eea550f0ae0b599780c4fe621407
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM186A TEX15 ITGAD	3.20e-04	63	94	3	0643435edf3280daf38c950e5bec287a9d5cb517
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM186A TEX15 ITGAD	3.20e-04	63	94	3	71c3afda6534401320791b714e3e2fe83094c914
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TIAM1 SYTL5 PYGM GRPR	3.33e-04	156	94	4	896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|Lung / Manually curated celltypes from each tissue	AFAP1L2 TIGIT SLC4A4 ITGAD	3.41e-04	157	94	4	af6eb2214340847bbab7cb209ea27cdc83b62a27
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFAP1L2 IGFBP3 SETBP1 TMEM132A	3.41e-04	157	94	4	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	Severe-B_naive-5\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYOM1 DACT3 PYGL ACVR1B	3.41e-04	157	94	4	a57ee4a6febdff3ee3d1645836695e6e7c055cf8
ToppCell	human_hepatoblastoma-Tumor_cells-T4\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RAN RPL32 IGFBP3 ZNF90	3.49e-04	158	94	4	53afcc8132cd61bae1adbdedb83e5bac6690bc8d
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AP4E1 RAN CCR9 CDC7	3.58e-04	159	94	4	a5509f0604ef0caef5ed1af83dd89c86686c73cc
ToppCell	COPD-Epithelial-PNEC\|COPD / Disease state, Lineage and Cell class	ASXL3 KCNJ6 SYT4 USH1C	3.58e-04	159	94	4	6018124980c55190928409f3bf41d846a118954a
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	ANK3 DSC2 ATRX ATAD5 PHF3 TEX15 ACVR1B SLC4A4	1.33e-06	190	95	8	4507_DN
Drug	Succimer	CUL3 RHOQ ZNF567 IGFBP3 ANK3 DSC2 ATRX BRCA2 ATAD5 ABCE1 PHF3 ASH1L TOPBP1 SUZ12 SIK3 IFI16 MXD4 CDC7	4.20e-06	1264	95	18	ctd:D004113
Drug	Magnetite Nanoparticles	CUL3 RHOQ ZNF567 IGFBP3 ANK3 DSC2 ATRX BRCA2 ATAD5 ABCE1 PHF3 ASH1L TOPBP1 SUZ12 SIK3 IFI16 MXD4 CDC7	6.88e-06	1310	95	18	ctd:D058185
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	TPR ANK3 DSC2 TIAM1 PHF3 ARHGEF38 IFI16	1.50e-05	190	95	7	4322_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	TPR ANK3 PHF3 ACVR1B MXD4 DENND4C SAMD4A	1.66e-05	193	95	7	3293_DN
Drug	1-N-Acetyl-Beta-D-Glucosamine	PYGL PYGM	1.72e-05	2	95	2	DB02320
Drug	3,5-dimethylphenyl isocyanate	PYGL PYGM	5.15e-05	3	95	2	CID000521488
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGL PYGM	5.15e-05	3	95	2	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGL PYGM	5.15e-05	3	95	2	CID000191554
Drug	hydan	PYGL PYGM	5.15e-05	3	95	2	CID000008360
Drug	EHMF	PYGL PYGM	5.15e-05	3	95	2	CID000033931
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGL PYGM	5.15e-05	3	95	2	CID000147839
Drug	pyridoxal 5'-methylenephosphonate	PYGL PYGM	5.15e-05	3	95	2	CID003082249
Drug	Plp 5'-mpa	PYGL PYGM	5.15e-05	3	95	2	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGL PYGM	5.15e-05	3	95	2	CID000191723
Drug	3'-FFdUrd	PYGL PYGM	5.15e-05	3	95	2	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGL PYGM	5.15e-05	3	95	2	CID000119518
Drug	AC1L8XK3	PYGL PYGM	5.15e-05	3	95	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGL PYGM	5.15e-05	3	95	2	CID000446801
Drug	NSC758405	PYGL PYGM	5.15e-05	3	95	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGL PYGM	5.15e-05	3	95	2	CID000151920
Drug	riboflavin tetraacetate	PYGL PYGM	5.15e-05	3	95	2	CID000094186
Drug	pyridoxal phosphoglucose	PYGL PYGM	5.15e-05	3	95	2	CID000196007
Drug	2,5-dimethyl-3-furanone	PYGL PYGM	5.15e-05	3	95	2	CID000085730
Drug	3,5-dinitrophenol	PYGL PYGM	5.15e-05	3	95	2	CID000011459
Drug	galocitabine	PYGL PYGM	1.03e-04	4	95	2	CID000065950
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGL PYGM	1.03e-04	4	95	2	CID000189134
Drug	AC1LAMW2	PYGL PYGM	1.03e-04	4	95	2	CID000491364
Drug	FdUrd-C8	PYGL PYGM	1.03e-04	4	95	2	CID000094262
Drug	Mem-CC	PYGL PYGM	1.03e-04	4	95	2	CID003081269
Drug	5-deoxyribose-1-phosphate	PYGL PYGM	1.03e-04	4	95	2	CID000135786
Drug	ingliforib	PYGL PYGM	1.03e-04	4	95	2	CID006451325
Drug	uric acid riboside	PYGL PYGM	1.03e-04	4	95	2	CID000164933
Drug	pseudo-dl-glucose	PYGL PYGM	1.03e-04	4	95	2	CID000125259
Drug	BCIp4A	PYGL PYGM	1.03e-04	4	95	2	CID000192417
Drug	pyridoxal diphosphate	PYGL PYGM	1.03e-04	4	95	2	CID000125696
Drug	3'-chloromethotrexate	PYGL PYGM	1.03e-04	4	95	2	CID000097703
Drug	AC1L9IMU	KCNJ6 PYGL PYGM	1.17e-04	23	95	3	CID000445825
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	TPR DSC2 ATRX ATAD5 PHF3 ACVR1B	1.51e-04	191	95	6	4303_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DSC2 TIAM1 ATRX ATAD5 PHF3 ASH1L	1.51e-04	191	95	6	6020_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	DLC1 IGFBP3 ATAD5 PHF3 ARHGEF38 KCNN2	1.60e-04	193	95	6	3250_UP
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	TPR DSC2 ATRX ATAD5 PHF3 SAMD4A	1.64e-04	194	95	6	4309_DN
Drug	Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	AP4E1 DLC1 DSC2 ATRX UTP14A GRPR	1.64e-04	194	95	6	4163_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	CUL3 TPR DSC2 ATAD5 ARHGEF38 IFI16	1.64e-04	194	95	6	4320_DN
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A	CUL3 ANK3 RIN2 SLC4A4 IFI16 GRPR	1.69e-04	195	95	6	1292_UP
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A	CUL3 DLC1 ANK3 SETBP1 TEX15 SLC4A4	1.69e-04	195	95	6	2152_UP
Drug	heptulose-2-P	PYGL PYGM	1.71e-04	5	95	2	CID000124823
Drug	m-anisidine	PYGL PYGM	1.71e-04	5	95	2	CID000010824
Drug	6-FPLP	PYGL PYGM	1.71e-04	5	95	2	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGL PYGM	1.71e-04	5	95	2	CID009576855
Drug	2-hydroxypropylphosphonate	PYGL PYGM	1.71e-04	5	95	2	CID000441028
Drug	DHPBU	PYGL PYGM	1.71e-04	5	95	2	CID000125914
Drug	6-FDPL	PYGL PYGM	1.71e-04	5	95	2	CID000129578
Drug	5'-isobutylthioinosine	PYGL PYGM	1.71e-04	5	95	2	CID003080910
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGL PYGM	1.71e-04	5	95	2	CID003082179
Drug	GlcMan	PYGL PYGM	1.71e-04	5	95	2	CID000152120
Drug	U66985	PYGL PYGM	1.71e-04	5	95	2	CID000127224
Drug	indirubin-5-sulphonate	PYGL PYGM	1.71e-04	5	95	2	CID005288641
Drug	AC1O3M08	PYGL PYGM	1.71e-04	5	95	2	CID006331955
Drug	AC1LCUXJ	PYGL PYGM	1.71e-04	5	95	2	CID000656425
Drug	6-amino-5-bromouracil	PYGL PYGM	1.71e-04	5	95	2	CID000080578
Drug	etafenone	PYGL PYGM	1.71e-04	5	95	2	CID000003275
Drug	ddEtUrd	PYGL PYGM	1.71e-04	5	95	2	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGL PYGM	1.71e-04	5	95	2	CID000125618
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; HL60; HT_HG-U133A	DLC1 ANK3 CCR9 TMEM132A TEX15 ACVR1B	1.74e-04	196	95	6	2914_UP
Drug	2,3-bis(3'-hydroxybenzyl)butyrolactone	RHOQ NTN4 OXTR ATRX BRCA2 PYROXD1 SYTL5 TOPBP1 ABCC5 SGO2 PRKDC MXD4 CDC7	1.76e-04	961	95	13	ctd:C029497
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; HL60; HT_HG-U133A	ANK3 PHF3 RIN2 UTP14A ACVR1B SAMD4A	1.78e-04	197	95	6	2908_UP
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	AP4E1 ATAD5 PHF3 RALGPS1 CCDC15 ACVR1B	1.83e-04	198	95	6	6838_DN
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A	DLC1 ANK3 TRO UTP14A GRPR MXD4	1.83e-04	198	95	6	2989_DN
Drug	Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A	DLC1 OXTR SETBP1 UTP14A TEX15 SAMD4A	1.83e-04	198	95	6	2708_UP
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A	RALGPS1 UTP14A ASH1L ACVR1B MXD4 SAMD4A	1.83e-04	198	95	6	3745_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; HL60; HT_HG-U133A	CUL3 ATRX UTP14A ACVR1B SLC4A4 MXD4	1.83e-04	198	95	6	2961_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	PHF3 TRO RALGPS1 GRPR MXD4 SAMD4A	1.83e-04	198	95	6	5598_UP
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	DSC2 TIAM1 BRCA2 PHF3 UTP14A MXD4	1.83e-04	198	95	6	3793_DN
Drug	Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A	IGFBP3 DSC2 PHF3 UTP14A ACVR1B GRPR	1.83e-04	198	95	6	6450_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	AP4E1 OXTR ANK3 TIAM1 USH1C MXD4	1.83e-04	198	95	6	3059_UP
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CUL3 PHF3 TEX15 ACVR1B GRPR MXD4	1.88e-04	199	95	6	7020_UP
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	IGFBP3 DSC2 ATAD5 PHF3 ACVR1B MXD4	1.88e-04	199	95	6	7000_DN
Drug	Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	IGFBP3 DSC2 RALGPS1 UTP14A ACVR1B MXD4	1.88e-04	199	95	6	3280_UP
Drug	valdecoxib; Down 200; 10uM; MCF7; HT_HG-U133A	DSC2 TRO CPA2 USH1C IFI16 SAMD4A	1.88e-04	199	95	6	6403_DN
Drug	Pilocarpine	RPL32 IGFBP3 ANK3 ATRX CCR9 KCNN2 ABCC5	1.93e-04	285	95	7	ctd:D010862
Drug	CV-araU	PYGL PYGM	2.56e-04	6	95	2	CID006441877
Drug	2-thiothymidine	PYGL PYGM	2.56e-04	6	95	2	CID003005944
Drug	Carbocyclic Bvdc	PYGL PYGM	2.56e-04	6	95	2	CID006438602
Drug	DNPP	PYGL PYGM	2.56e-04	6	95	2	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGL PYGM	2.56e-04	6	95	2	CID000082693
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGL PYGM	2.56e-04	6	95	2	CID000152984
Drug	EdUMP	PYGL PYGM	2.56e-04	6	95	2	CID003085112
Drug	4-hydroxyacetophenone	PYGL PYGM	2.56e-04	6	95	2	ctd:C031335
Drug	5'-deoxy-5'-chloroformycin	PYGL PYGM	2.56e-04	6	95	2	CID000126430
Drug	NSC-97433	PYGL PYGM	2.56e-04	6	95	2	CID000001803
Drug	5-n-propylthioadenosine	PYGL PYGM	2.56e-04	6	95	2	CID000656428
Drug	AzddCyd	PYGL PYGM	2.56e-04	6	95	2	CID000451374
Drug	5-Ffdru	PYGL PYGM	2.56e-04	6	95	2	CID000065561
Drug	AR-L57	PYGL PYGM	2.56e-04	6	95	2	CID000156890
Drug	Carbocyclic Ivdu	PYGL PYGM	2.56e-04	6	95	2	CID006439191
Drug	alpha-(fluoromethyl)dehydroornithine	PYGL PYGM	3.57e-04	7	95	2	CID006439607
Drug	6-fluoropyridoxal	PYGL PYGM	3.57e-04	7	95	2	CID003080803
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGL PYGM	3.57e-04	7	95	2	CID000356019
Drug	heptenitol	PYGL PYGM	3.57e-04	7	95	2	CID000188267
Disease	level of triacylglycerol (56:6) in blood serum	GATAD2A ZNF90 SIK3	1.59e-05	16	92	3	OBA_2020007
Disease	unipolar depression, bipolar disorder	GSDME ANK3 ASXL3 SETBP1 KDM2B	1.32e-04	156	92	5	EFO_0003761, MONDO_0004985
Disease	brain disease (implicated_via_orthology)	STIM2 TIAM1	1.43e-04	6	92	2	DOID:936 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	CUL3 ASXL3 SETBP1 ASH1L	2.09e-04	93	92	4	C1535926
Disease	asparaginase-induced acute pancreatitis	CPA2 C3orf20	3.41e-04	9	92	2	EFO_1001507
Disease	level of Ceramide (d42:1) in blood serum	GATAD2A SIK3	4.26e-04	10	92	2	OBA_2045187
Disease	level of Triacylglycerol (51:3) in blood serum	GATAD2A SIK3	4.26e-04	10	92	2	OBA_2045163
Disease	inositol measurement	SETBP1 SYT4	8.54e-04	14	92	2	EFO_0010504
Disease	MYELODYSPLASTIC SYNDROME	ATRX BRCA2 SETBP1	1.22e-03	67	92	3	C3463824
Disease	Malignant Glioma	ATRX BRCA2 SUZ12	1.38e-03	70	92	3	C0555198
Disease	mixed gliomas	ATRX BRCA2 SUZ12	1.38e-03	70	92	3	C0259783
Disease	FEV/FEC ratio	NTN4 DLC1 STRBP UTP14A MRPL30 ARHGEF38 ANKS1B SYT4 SUZ12 ACVR1B GRPR	1.53e-03	1228	92	11	EFO_0004713
Disease	Colorectal Carcinoma	DLC1 IGFBP3 TIAM1 KALRN ABCE1 SETBP1 ABCC5 CSMD3	1.59e-03	702	92	8	C0009402
Disease	periodontal measurement	ASH1L IFI16	2.54e-03	24	92	2	EFO_0007780
Disease	Glioma	ATRX BRCA2 SUZ12	2.57e-03	87	92	3	C0017638
Disease	Intellectual Disability	AP4E1 SETBP1 ASH1L SMARCC2 SERAC1 SUZ12	2.78e-03	447	92	6	C3714756

Protein segments in the cluster

Peptide	Gene	Start	Entry
TKKTVSIKVRHIGLI	USH1C	156	Q9Y6N9
LIEKAKALHISRSKV	ATAD5	706	Q96QE3
ILKKVTHFSIVLTAK	DENND10P1	81	Q6NSW5
AIKTTIKHPRKALKS	ASH1L	111	Q9NR48
LAVVTHRVKKAIDFK	CSMD3	441	Q7Z407
IAHRDLKSKNILVKK	ACVR1B	331	P36896
ISKKSKRVTNHLKIL	ARHGEF38	316	Q9NXL2
RLKSSVKAVILKDSK	GSDME	461	O60443
LGSSVIHKEKQVRKK	AFAP1L2	221	Q8N4X5
LEKFIHSVIISKRSK	C19orf18	171	Q8NEA5
HSVIISKRSKNIKKK	C19orf18	176	Q8NEA5
RLSKSIIKHSIDKSK	AKAP11	941	Q9UKA4
VKSIVDFIKSHGKVK	CPA2	286	P48052
QTKVLKKRHTKEKVL	DSC2	116	Q02487
IKVKNHSVLQRTEKK	ASXL3	861	Q9C0F0
ADTVSHKFRRKSKVK	AP4E1	786	Q9UPM8
IKDRKVKAKSIVFHR	RAN	126	P62826
KIRAEILSHFVKIAK	RALGPS1	116	Q5JS13
VKKIKPKVVSRTIFH	ANKS1B	661	Q7Z6G8
QKKALKVEHTSRLKA	GATAD2A	446	Q86YP4
TLSLLKRAKVHIKKL	MXD4	91	Q14582
HIVEASIRAKLIKSK	KCNJ6	231	P48051
NTKLVKKIDHAKVRK	KCNN2	436	Q9H2S1
SIVKKCIHKATRKDV	KALRN	2696	O60229
KIIAKVKSSSKEVAH	OPN5	221	Q6U736
SSVKLISKAKIRTVK	OXTR	261	P30559
HKNGARKSAKKILIV	ITGAD	241	Q13349
SAIRKHLKSKTVLFV	ABCC5	726	O15440
ARVVKRFILHAKKTA	ABCE1	501	P61221
VRKVAETKEKSKHLK	ATRX	936	P46100
FRKKEVVEILSHKKA	GRID2IP	886	A4D2P6
RKRHAAEKQKKKTVI	KDM2B	16	Q8NHM5
VFVKIKASHALKKKI	DACT3	601	Q96B18
QKVRTSKTRKKIFHE	BRCA2	321	P51587
VLSRKLATKKKAIST	CDC7	316	O00311
RILKKASKTHKQRVE	FAM32A	76	Q9Y421
TSKLHRVKIQTVAAK	CUL3	666	Q13618
PVRKTTKIHTKAKVT	C3orf20	631	Q8ND61
HVKKQIESRKRLAKT	GRPR	251	P30550
KSSKHKALKVTITVL	CCR9	246	P51686
AKRTKQEIKTAHKLA	DENND4C	746	Q5VZ89
TVKVRKSQLKEVCKH	ANK3	3981	Q12955
SHIKVIKTRKNKKDI	IFI16	756	Q16666
VSALNKIKAIARKTK	DCST2	146	Q5T1A1
VAKKRLAIISSLKSK	FAM186A	1951	A6NE01
ILKKVTHFSIVLTAK	DENND10	81	Q8TCE6
KIIIIKKGHAKDSQR	IGFBP3	171	P17936
EKKHKVKTRVLRKTL	SYT4	201	Q9H2B2
RHTGKIKTIKIFKNS	TARS3	346	A2RTX5
SKATKHKTLVIKKSV	SYTL5	621	Q8TDW5
KKHTVKKRIGSRCIN	RHOQ	186	P17081
KELHKAVRKVLATSA	SERAC1	96	Q96JX3
KIVKKRTKKFIRHQS	RPL32	11	P62910
GKDRAKSKKVHRIVS	RHBDL2	36	Q9NX52
VNAKLKVVKHLIRIK	MRPL30	106	Q8TCC3
LTLRIKVKKGLHVTA	TMEM132A	286	Q24JP5
HVEVNVKIKKVLKST	NTN4	541	Q9HB63
TKHIFKIITKEDRLK	POP4	161	O95707
STVVRHLKQIGKVKK	SETMAR	441	Q53H47
LIVKHIRKKQAKKAA	SIGLECL1	136	Q8N7X8
KRATHLVTKAKVAIK	SIK3	81	Q9Y2K2
IKRHLKDKRISKTTK	SGO2	16	Q562F6
KKTAKLHVAVKVLQA	STRBP	436	Q96SI9
IKKTLRGKTVVLVTH	ABCC12	646	Q96J65
HEKTAKSKTRSLLKR	DLC1	656	Q96QB1
VKAKHLAAVEERKIK	SMARCC2	871	Q8TAQ2
LRAVAKKVHSTIQKI	SRBD1	271	Q8N5C6
RHRLASFKTVIKKKG	CCDC15	181	Q0P6D6
RSVVSINHKKLVKEK	ZNF567	96	Q8N184
VHKSTKMQKKVLSLR	RIN2	121	Q8WYP3
LVHKKNKKVESATRR	TIAM1	446	Q13009
VARIHSEILKKTIFK	PYGM	456	P11217
KASKARKTIAKVINT	TRO	256	Q12816
KLIAEKSEAKIAHKR	PYROXD1	196	Q8WU10
KIKKKRSTVFGTLHV	STIM2	386	Q9P246
EKTRKAIVAAKSKIA	TPR	1551	P12270
EAFSKKHQRKVAIKV	TSSK3	26	Q96PN8
VLLVKVCHKKRKDVS	SUZ12	186	Q15022
VIHSKTKVNVKSVKR	PHF3	516	Q92576
IKHSKSRDSFLKRVK	RPL21	96	P46778
RITTRHKKQLKKCSV	UTP14A	756	Q9BVJ6
VALTRKKKALRIHSV	TIGIT	161	Q495A1
RIIEKKHVSLNKAKK	PRKDC	1136	P78527
KAFKRSSVLSKHKII	ZNF90	516	Q03938
ITAVIVNRKEHKLKK	SLC4A4	801	Q9Y6R1
KVKKSREKRSLASHL	GTF3A	311	Q92664
KCLSRKLDKAVVHLK	TEX15	991	Q9BXT5
HKRKKRQSIKAVVEK	SETBP1	416	Q9Y6X0
VAKIHSDIVKTKVFK	PYGL	456	P06737
HKVVVCVSKKLSKKQ	TOPBP1	906	Q92547
KDIHTTTGKIKRAVL	PTDSS1	251	P48651
TKGARHKIVISIQKL	SAMD4A	366	Q9UPU9
FVSRKKVNTIKKLHQ	ZNF7	621	P17097
ISRNKTKQVHLSRKK	ZNF518B	886	Q9C0D4
LKCKVANIKKETHIV	MYOM1	1376	P52179
HSKRLKVKLTIQKEV	NMD3	106	Q96D46